CAS: 1354039-86-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ACT 335827 REF: 3D-EEC03986CAS: 1354039-86-3 | Min. 95% | 246,00 €~1.960,00 € | Vie 21 Mar 25 |
 | ACT 335827 REF: TM-T21850CAS: 1354039-86-3 | - - - | 1.040,00 €~4.194,00 € | Vie 11 Abr 25 |
ACT 335827
CAS:1354039-86-3
ACT 335827 is a drug that is effective in the treatment of hypertension. It has …
Fórmula:
C31H38N2O5
Pureza:
Min. 95%
Peso molecular:
518.64 g/mol
Ref: 3D-EEC03986
| 1mg | 246,00 € | ||
| 2mg | 384,00 € | ||
| 5mg | 683,00 € | ||
| 10mg | 977,00 € | ||
| 25mg | 1.960,00 € |
Entrega estimada en Estados Unidos, el Viernes 21 de Marzo de 2025
ACT 335827
CAS:1354039-86-3
ACT-335827: oral, brain-penetrant OXR1 selective antagonist; IC50: 6 nM (OXR1), 417 nM (OXR2); for neurological …
Fórmula:
C31H38N2O5
Forma y color:
Solid
Peso molecular:
518.64
Ref: TM-T21850
| 10mg | 1.040,00 € | ||
| 50mg | 4.194,00 € |
Entrega estimada en Estados Unidos, el Viernes 11 de Abril de 2025
